Algotec Research and Development Limited

17/03/2022

A lovely message from one of our patients yesterday. Neuromodulation changing lives!

22/07/2020

Percutaneous Electrical Nerve Stimulation for Facial Pain
Girish Vajramani. Centre for Functional Neurosurgery, Wessex Neurological Centre, Department of Neurosurgery, University Hospital Southampton, Southampton, UK.
Published online: Slavin KV (ed): Neuromodulation for Facial Pain. Prog Neurol Surg. Basel, Karger, 2020, vol 35, pp 1–15 (DOI:
10.1159/000509621)

Abstract
Percutaneous electrical nerve stimulation (PENS) is a novel, minimally invasive and useful treatment modality. Its use in complex facial pain has been on the rise, and its utility will further increase with the advances in the technology and renewed interest in the field of peripheral neuromodulation. PENS therapy can be used both as diagnostic and therapeutic option. The precise mechanism of action is not known, although a combination of electrical neuromodulation and release of endogenous morphine- like substance in the central nervous system appears as plausible explanation. We analyse the various studies in the literature and discuss the Southampton data regarding facial pain treatment with PENS therapy. We believe that PENS therapy for facial pain and headache is currently underutilised. It is safe, economical and should certainly be part of the armamentarium in the treatment of complex facial pain and headache. © 2020 S. Karger AG, Basel

Paper available for downlaod at www.algotec-ltd.com/clinical

27/02/2020

27/02/2020

The glial cells of the nervous system have been eclipsed in importance by neurons for decades. But glia are turning out to be central to many neurological functions, including pain perception.

09/10/2019

Nikola Tesla Was Right! "We've Found The Magic Frequency" ***SUBLIMINAL PROGRAMS*** - https://bit.ly/2z7zyfG ================================================...

24/07/2019

24/07/2019

24/07/2019

18/07/2019

Not for humans yet

14/05/2019

VALENCIA, Calif., May 13, 2019 /PRNewswire/ -- Bioness, Inc., the leading provider of advanced, clinically supported medical devices for the treatment of...

20/03/2019

Our lives are all busy, so it’s lovely when a patient takes the time to let us know how they have gotten on 😊

11/01/2019

25/08/2018

This may be very good news for chronic pain sufferers in Australia!

http://www.pulseline.com.au/featured/change-in-canberra

The events of the week in Canberra have thrown the plans of just about every major stakeholder into chaos.

24/09/2017

Joint HHS-DoD-VA initiative will award multiple grants totaling $81 million.

17/08/2017

It has been an exciting day for all, as Dr's Peter Georgius and Paul Frank treat a patient with Occipital neuralgia at Nambour Selangor Private Hospital in Queensland - the first hospital in Australia to receive our new NeuroStimulator PENS therapy II.

Algotec's NeuroStimulator PENS therapy II peripheral nerve stimulator has been engineered to improve patient outcomes and extend the benefits of PENS therapy to more patients suffering from chronic neuropathic pain syndromes.

23/05/2017

We are very excited to announce that our NeuroStimulator PENS therapy II peripheral nerve stimulator, received CE approval last week.

The NeuroStimulator II was used yesterday for the first time at the University Hospital Southampton in the UK, by neurosurgeon Girish Vajramani, to treat one patient with chronic migraine, and another with nummular headache.

Mr Vajramani finished a functional neurosurgery fellowship at the Walton Centre, Liverpool, before joining the University Hospital Southampton to set up a functional neurosurgery service there.

Mr Vajramani has successfully set up the spinal cord stimulation and intrathecal baclofen therapy service, and is currently setting up the deep brain stimulation service for Parkinson’s and other movement disorders. He is the lead neurosurgeon for epilepsy surgery, performing resective surgeries as well as vagus nerve stimulation. His areas of interest include trigeminal neuralgia, complex facial pain and other neurovascular conflict syndromes, such as hemifacial spasm. He is also interested in occipital nerve stimulation for intractable migraines and cluster headaches.

10/04/2017

We are very excited to welcome Chine House Equine Hospital, as our 10th equine centre in the UK to start using PENS therapy (EquiPENS), for trigeminal mediated headshaking in horses.

EquiPENS is now also being used in Denmark, Sweden and the Netherlands, and is developing into an exciting deviation from our intended human indications.